Patents by Inventor Takeshi Goto

Takeshi Goto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050270518
    Abstract: A method for determining a position of a reference point in which there is no influence of aberration of a camera lens or the like, but an error caused by a failure in shape of an alignment mark can be reduced. An alignment mark consisting of a plurality of pattern portions (and background portions) centering at a design reference point is provided in advance. Positions of centers of border lines of the patterns are calculated. Obtained coordinate values of the centers are averaged in each axial direction. The averaged coordinate values are regarded as coordinate values of a machining reference point. Thus, even when a defect occurs in any pattern portion, an error caused by the defect is reduced so that the accuracy in machining can be improved.
    Type: Application
    Filed: June 1, 2005
    Publication date: December 8, 2005
    Applicant: Hitachi Via Mechanics Ltd.
    Inventors: Hiroyuki Sugawara, Takeshi Goto, Kounosuke Kitamura, Hiroshi Aoyama
  • Publication number: 20050192343
    Abstract: Agents potentiating nerve growth factor activity are provided for treating Alzheimer's disease which contain as the active ingredient dodecatrienoic acid derivatives represented by the general formula (I): wherein X represents hydrogen, CHO, COOH, COOR (wherein R represents an ester residue or an addition salt comprising an alkali metal salt or an organic acid salt group), provided that in case where X is COOH, it is bonded to the carbon atom at the position marked with * so as to form a lactam O?C—O—.
    Type: Application
    Filed: May 3, 2005
    Publication date: September 1, 2005
    Inventors: Takeshi Goto, Toshio Itoyama, Hidenao Fukushima, Yuto Kamei
  • Publication number: 20050143310
    Abstract: A medicament for treating neurodegenerative diseases, comprising as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from the C-terminal of selenoprotein P. An excellent medicament for treating neurodegenerative diseases, especially suitable for treating neurodegenerative diseases with ataxia as a principal symptom is provided.
    Type: Application
    Filed: May 10, 2002
    Publication date: June 30, 2005
    Inventors: Masaki Hirashima, Takeshi Naruse, Hiroaki Maeda, Chikateru Nozaki, Takeshi Goto, Katsuhiko Akiyama, Hidenao Fukushima
  • Publication number: 20050143311
    Abstract: A peptide fragment or a series of peptide fragments containing one or more selenocysteine that has a lowered toxicity than selenocystine and that exhibits a cytotoxicity-inhibitory activity. The peptide fragment or a series of peptide fragments according to the present invention has preferably the amino acid sequence from 260th to 362nd amino acid residues from the C-terminal of selenoprotein P, or said amino acid sequence with one or several amino acid residues therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences. A screening method for a peptide fragment having the cytotoxicity-inhibitory activity is also provided.
    Type: Application
    Filed: May 10, 2002
    Publication date: June 30, 2005
    Inventors: Masaki Hirashima, Takeshi Naruse, Hiroaki Maeda, Chikateru Nozaki, Takeshi Goto, Katsuhiko Akiyama, Wataru Hattori
  • Publication number: 20050082879
    Abstract: A vehicle body structure for efficiently transmitting and dispersing collision energy is provided. The vehicle body structure includes a floor tunnel provided in the center of the vehicle width and extending longitudinally of a vehicle body. Side portions of the floor tunnel are joined to floor frame members provided on the right and left thereof. A rear portion of the floor tunnel is joined to center frame members provided rearward thereof. Collision energy acting on the front end of the floor tunnel is transmitted and dispersed to the right and left floor frame members and the center frame members. Collision energy acting on the floor frame members is transmitted and dispersed to the floor tunnel and the center frame members. Collision energy transmitted to the center frame memerbs is transmitted and dispersed through a plurality of crossmembers disposed rearward of the floor tunnel to the rear of the vehicle body.
    Type: Application
    Filed: October 12, 2004
    Publication date: April 21, 2005
    Applicant: Honda Motor Co., Ltd.
    Inventors: Takeshi Goto, Shigeto Yasuhara
  • Publication number: 20050084476
    Abstract: Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect of lowering blood phosphorus level and another effect of suppressing phosphorus excretion into the urine.
    Type: Application
    Filed: November 9, 2004
    Publication date: April 21, 2005
    Inventors: Takeshi Goto, Kazuhisa Yoshitake, Hiroshi Sorimachi, Kazuteru Moriyama
  • Publication number: 20050032975
    Abstract: A protective member for protecting electric wires includes: a non-woven cloth layer having flexibility and made of a chlorine-free resin; and an outer resin layer laminated monolithically on outer surface of the non-woven cloth layer, and made of a chlorine-free and fire-retardant resin, wherein a thickness of the outer resin layer is configured to be not more than a thickness of the non-woven cloth layer, and wherein a total thickness of the non-woven cloth layer and the outer resin layer is configured to have a predetermined wear resistance.
    Type: Application
    Filed: July 9, 2004
    Publication date: February 10, 2005
    Applicants: SUMITOMO WIRING SYSTEMS, LTD., KYOSHIN CO., LTD., GOKO CORPO.
    Inventors: Takahiro Sakaguchi, Atsushi Fujisawa, Takamichi Yamashita, Hiromichi Tsuji, Takeshi Goto
  • Patent number: 6844372
    Abstract: An cross-linked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having two or more functional groups capable of reacting with amino and/or imino group contained in the polymer (A). The resin or salt has a water absorption ratio of 4.0 or lower.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: January 18, 2005
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Takeshi Goto, Kazuhisa Yoshitake, Kazuteru Moriyama, Shuichi Toriya, Tsutomu Yuasa, Hideyuki Nishibayashi
  • Publication number: 20050009215
    Abstract: A semiconductor device manufacture method includes the steps of forming a resist layer above a work target layer; exposing and developing the resist layer to form resist patterns including isolated pattern and dense patterns; monitoring widths of isolated and dense pattern of the resist patterns to determine trimming amounts of linewidths to be reduced; determining etching conditions for realizing the trimming amounts of both the isolated and dense patterns, the etching conditions using mixed gas of a gas having a function of mainly enhancing etching and a gas having a function of mainly suppressing etching; trimming the resist pattern under said determined etching conditions; and etching the work target layer by using said trimmed resist patterns. A desired pattern width an be realized stably by trimming using plasma etching.
    Type: Application
    Filed: July 6, 2004
    Publication date: January 13, 2005
    Applicant: FUJITSU LIMITED
    Inventors: Takeshi Goto, Mitsugu Tajima, Takayuki Yamazaki, Takaya Kato
  • Publication number: 20040258741
    Abstract: Percutaneous absorption preparations for treating dementia which contain an adhesive composition, characterized in that the adhesive composition contains the active ingredient in a dispersed state, the active ingredient is released at a pharmacologically effective rate and the skin permeation rate thereof is at least 1.2 &mgr;g/cm2/h. Thus, it is possible to provide percutaneous absorption preparations whereby the therapeutic effect can be sustained over a prolonged period of time without elevating the concentration of the active ingredient in the plasma to such a level as causing the expression of side effects in the administration of remedies for dementia.
    Type: Application
    Filed: April 14, 2004
    Publication date: December 23, 2004
    Inventors: Takaaki Terahara, Arata Toshimitsu, Kengo Uemura, Naruhito Higo, Takeshi Goto, Shuji Sato
  • Patent number: 6815430
    Abstract: The base sequence for the expression of a therapeutic gene and the medicament for gene therapy are disclosed. There is also disclosed the base sequence for the expression of a therapeutic gene, said sequence being shown in any one of from (a) to (d) and capable of directing the expression of the therapeutic gene specifically to squamous epithelium: (a) the base sequence set forth in SEQ ID NO:1 in the Sequence Listing; (b) the base sequence set forth in SEQ ID NO:18 in the Sequence Listing; (c) the base sequence set forth in SEQ ID NO:17 in the Sequence Listing; and (d) the base sequence set forth in SEQ ID NO:16 in the Sequence Listing. Moreover, there is disclosed the medicament for gene therapy containing a therapeutic gene downstream any of the above-mentioned base sequences, capable of directing the expression of the therapeutic gene specifically to squamous epithelium.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: November 9, 2004
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Kazuhiro Yuda, Katsuhiko Akiyama, Takeshi Goto, Katsuyuki Hamada
  • Patent number: 6794367
    Abstract: The invention provides solid preparations for oral administration of gene-related drugs comprising a core containing the gene-related drug with a coating which does not disintegrated in small intestines, wherein said preparations can be easily tabletted, remain stable during the preparation process and said drug can be efficiently absorbed in digestive tracts.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: September 21, 2004
    Assignee: Hisamitsu Pharmaceutical, Inc.
    Inventors: Norifumi Tanida, Takeshi Goto, Jun Aoki
  • Publication number: 20040180113
    Abstract: Provide milk powders for confectionery and bakery products that, when added during the production of confectionery and bakery products, can increase the volume of breads, pancakes, cakes, pies, etc., and further add a desirable texture and feel in the mouth to breads, pancakes and cakes. Obtain milk powders for confectionery and bakery products containing 4 to 10 weight-percent of non-protein nitrogen (based on the weight of converted protein) and 1 to 20 weight-percent of ash in a manner keeping the ratio of non-protein nitrogen to total nitrogen to 0.5 or less, by intermixing, as appropriate, dairy ingredients containing non-protein nitrogen with other dairy ingredients such as whole milk powders, skim milk powders, buttermilk powders, whey powders, milk minerals, whey protein concentrates and milk protein concentrates.
    Type: Application
    Filed: May 10, 2004
    Publication date: September 16, 2004
    Inventors: Atsushi Serizawa, Takeshi Goto, Mikako Chino, Minoru Morita, Harunobu Yamamoto
  • Publication number: 20040059065
    Abstract: A crosslinked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having a vinyl group capable of reacting in Michael addition reaction and a carboxylic ester group, and thus by making the amino and/or imino groups contained in the polymer (A) add to the vinyl group in the compound (B) and form a amide-bond with the carboxylic ester group in the compound (B).
    Type: Application
    Filed: May 9, 2003
    Publication date: March 25, 2004
    Inventors: Takeshi Goto, Kazuhisa Yoshitake, Kazuteru Moriyama, Shuichi Toriya, Tsutomu Yuasa, Hideyuki Nishibayashi
  • Publication number: 20040052780
    Abstract: There are provided immunosuppressants with few side effects that can be used to suppress rejection involving organ transplantation, and the immunosuppressants comprising antibodies against histone H1 which specifically recognize antigenic proteins may be used to suppress immunity in mammals for treatment or prevention of rejection involving organ transplantation.
    Type: Application
    Filed: March 4, 2003
    Publication date: March 18, 2004
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Kazuhisa Ono, Seiji Kawamoto, Takeshi Goto, Shuji Sato, Sigeru Goto
  • Publication number: 20040005708
    Abstract: There are disclosed polypeptide derivatives and their pharmaceutically acceptable salts represented by formula (1), as well as their utility as nucleic acid carriers in gene therapy.
    Type: Application
    Filed: November 15, 2002
    Publication date: January 8, 2004
    Inventors: Takeshi Goto, Masaru Nakanishi, Keishi Yonemura, Naoya Oomori, Takashi Yasukouchi, Masanao Oya
  • Patent number: 6620834
    Abstract: Medicinal compositions for colorectal cancer to be administered to the large intestine by taking advantage of preparations disintegrating in the large intestine, characterized by containing a cyclooxygenase inhibitor and an HMG-CoA reductase inhibitor. These compositions are appropriate for inhibiting the postoperative liver metastasis and recurrence of colorectal cancer.
    Type: Grant
    Filed: April 15, 2002
    Date of Patent: September 16, 2003
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Norifumi Tanida, Takeshi Goto, Naoko Tomizawa
  • Patent number: 6620788
    Abstract: An absorption enhancer for the large intestine most suitable for an oral preparation, with a disintegration property in the large intestine, especially the absorption enhancer for the large intestine mixed with a hydrophilic medium and an absorption enhancer is provided.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: September 16, 2003
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Norifumi Tanida, Takeshi Goto, Satoshi Suzuki
  • Publication number: 20030158097
    Abstract: Novel medicinal compositions aiming at delivering a medicine to a specific site of the large intestine; and preparations for intestinal administration with the use of the same. Namely, medicinal compositions, whereby a medicine can be delivered to a specific site of the large intestine, characterized by containing a P-glycoprotein modifier; and preparations for intestinal administration with the use of the same.
    Type: Application
    Filed: November 21, 2002
    Publication date: August 21, 2003
    Inventors: Norifumi Tanida, Takeshi Goto, Yuji Kurosaki
  • Publication number: 20030148929
    Abstract: A novel nucleic acid carrier and a pharmaceutical composition for gene therapy are disclosed. The nucleic acid carrier of this invention is characterized by containing a polypeptide comprising diaminobutyric acid with a suitable number of residues and/or a pharmaceutically acceptable salt thereof. The nucleic acid carrier of this invention can form a complex with a variety of therapeutic genes that is safe and has extremely low immunogenicity (the pharmaceutical composition of this invention); and it can allow the therapeutic gene to be introduced into cells efficiently and safely whereby high expression of the gene in the cells can be realized.
    Type: Application
    Filed: December 12, 2002
    Publication date: August 7, 2003
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Takeshi Goto, Keishi Yonemura, Tetsuji Kuwahara, Masanao Oya, Katsuhiko Akiyama